MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities (note 5)
$187,640K
Cash and cash
equivalents
$41,157K
Prepaid expenses and
other current assets
$15,332K
Accounts receivable
$4,638K
Total current assets
$248,767K
Long-term marketable
securities (note 5)
$41,787K
Operating lease
right-of-use assets (note 14)
$15,724K
Property and equipment,
net (note 7)
$15,502K
Goodwill (note 6)
$12,016K
Long-term prepaids and
other assets
$6,674K
Deferred tax asset(note
13)
$4,707K
Intangible assets, net
(note 8)
$1,350K
Total assets
$346,527K
Total liabilities and
stockholdersequity
$346,527K
Total stockholders
equity
$268,501K
Total liabilities
$78,026K
Accumulated deficit
-$953,160K
Accumulated other
comprehensive loss
-$6,079K
Common shares, 0.00001
par value...
$1,105,176K
Total current
liabilities
$42,318K
Long-term portion of
operating lease liability...
$14,796K
Deferred revenue (note
11)
$14,606K
Deferred tax liability
(note 13)
$6,028K
Other long-term
liabilities(note 9)
$278K
Additional paid-in capital
$114,626K
Exchangeable shares, no par
value, 553,184 issued...
$7,938K
Accounts payable and
accrued liabilities...
$36,346K
Current portion of
operating lease liability...
$3,471K
Deferred revenue and
other consideration...
$2,418K
Income tax payable
(note 13)
$83K
Back
Back
Balance Sheet
source: myfinsight.com
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)